Alpha Financial Partners, LLC Abb Vie Inc. Transaction History

Alpha Financial Partners, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 09, 2024	BUY	$154.79 - $180.76 $21,515 - $25,125	139 Added 8.33%	1,808 $310 Million
Q1 2024 May 13, 2024	BUY	$159.82 - $182.1 $319 - $364	2 Added 0.12%	1,669 $304 Million
Q4 2023 Jan 29, 2024	SELL	$137.6 - $154.97 $109,667 - $123,511	-797 Reduced 32.35%	1,667 $258 Million
Q3 2023 Nov 07, 2023	BUY	$133.59 - $154.65 $267 - $309	2 Added 0.08%	2,464 $367 Million
Q2 2023 Jul 27, 2023	BUY	$132.51 - $164.9 $3,445 - $4,287	26 Added 1.07%	2,462 $332 Million
Q1 2023 May 10, 2023	SELL	$144.61 - $166.54 $4,772 - $5,495	-33 Reduced 1.34%	2,436 $388 Million
Q4 2022 Feb 16, 2023	BUY	$138.31 - $165.87 $341,487 - $409,533	2,469 New	2,469 $399 Million

3,853

1.25B

16.8M

12.2M

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $317B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

Get notified when there are updates to the investment portfolio of Alpha Financial Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Alpha Financial Partners, LLC with notifications on news.